1. Alavi A, Sibbald RG, Phillips TJ, et al. What’s new: management of venous leg ulcers: approach to venous leg ulcers. J Am Acad Dermatol 2016; 74: 627-40.
2. Agale SV. Chronic leg ulcers: epidemiology, aetiopathogenesis, and management. Ulcers 2013 (https:/ / www .hindawi .com/ journals/ ulcers/ 2013/ 413604/ ).
3. Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 2002; 46: 381-6.
4. Carpentier PH, Maricq HR, Biro C, Ponçot-Makinen CO, Franco A. Prevalence, risk factors, and clinical patterns of chronic venous disorders of lower limbs: a population-based study in France. J Vasc Surg 2004; 40: 650-9.
5. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005; 15: 175-84.
6. Mekkes JR, Loots MA, Van Der Wal AC, Bos JD. Causes, investigation and treatment of leg ulceration. Br J Dermatol 2003; 148: 388-401.
7. Rice JB, Desai U, Cummings AK,
Birnbaum HG, Skornicki M, Parsons N. Burden of venous leg ulcers in the United States. J Med Econ 2014; 17: 347-56.
8. Rice JB, Desai U, Cummings AKG, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care 2014; 37: 651-8.
9. Raffetto JD. Pathophysiology of wound healing and alterations in venous leg ulcers — review. Phlebology 2016; 31: Suppl:56-62.
10. Gohel MS, Windhaber RA, Tarlton JF, Whyman MR, Poskitt KR. The relationship between cytokine concentrations and wound healing in chronic venous ulceration. J Vasc Surg 2008; 48: 1272-7.
11. Mannello F, Raffetto JD. Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research. Am J Transl Res 2011; 3: 149-58.
12. Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in chronic wounds. Int J Mol Sci 2016; 17: E2085.
13. Lepäntalo M, Apelqvist J, Setacci C, et al. Chapter V: diabetic foot. Eur J Vasc Endovasc Surg 2011; 42: Suppl 2: S60-S74.
14. Clayton W, Elasy TA. A review of the pathophysiology, classification, and treatment of foot ulcers in diabetic patients. Clin Diabetes 2009; 27: 52-8.
15. Schaper NC, Huijberts M, Pickwell K. Neurovascular control and neurogenic inflammation in diabetes. Diabetes Metab Res Rev 2008; 24: Suppl 1: S40-S44.
16. Alavi A, Sibbald RG, Mayer D, et al. Diabetic foot ulcers: Part I. Pathophysiology and prevention. J Am Acad Dermatol 2014; 70(1): 1.e1-18.
17. Thomas DR. Does pressure cause pressure ulcers? An inquiry into the etiology of pressure ulcers. J Am Med Dir Assoc 2010; 11: 397-405.
18. McGee SR, Boyko EJ. Physical examination and chronic lower-extremity ischemia: a critical review. Arch Intern Med 1998; 158: 1357-64.
19. Khan TH, Farooqui FA, Niazi K. Critical review of the ankle brachial index. Curr Cardiol Rev 2008; 4: 101-6.
20. Nishio H, Minakata K, Kawaguchi A, et al. Transcutaneous oxygen pressure as a surrogate index of lower limb amputation. Int Angiol 2016; 35: 565-72.
21. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001; 24: 250-6.
22. Best practice guidelines: wound management in diabetic foot ulcers. London: Wounds International, 2013 (http://www .woundsinternational .com/ best-practices/view/ best-practice-guidelines-wound-management-in-diabetic-foot-ulcers).
23. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with
diabetes. Diabetes Care 2006; 29: 1288-93.
24. Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag 2007; 3: 65-76.
25. Noor S, Zubair M, Ahmad J. Diabetic foot ulcer — a review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr 2015; 9: 192-9.
26. Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas DW. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 2005; 55: 143-9.
27. Morales Lozano R, González Fernández ML, Martinez Hernández D, Beneit Montesinos JV, Guisado Jiménez S, Gonzalez Jurado MA. Validating the probe-tobone test and other tests for diagnosing chronic osteomyelitis in the diabetic foot. Diabetes Care 2010; 33: 2140-5.
28. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54(12):e132-73.
29. Kirsner RS. The Wound Healing Society chronic wound ulcer healing guidelines update of the 2006 guidelines —blending old with new. Wound Repair Regen 2016; 24: 110-1.
30. Marston W, Tang J, Kirsner RS, Ennis W. Wound Healing Society 2015 update on guidelines for venous ulcers. Wound Repair Regen 2016; 24: 136-44.
31. Federman DG, Ladiiznski B, Dardik A, et al. Wound Healing Society 2014 update on guidelines for arterial ulcers. Wound Repair Regen 2016; 24: 127-35.
32. Lavery LA, Davis KE, Berriman SJ, et al. WHS guidelines update: diabetic foot ulcer treatment guidelines. Wound Repair Regen 2016; 24: 112-26.
33. Gould L, Stuntz M, Giovannelli M, et al. Wound Healing Society 2015 update on guidelines for pressure ulcers. Wound Repair Regen 2016; 24: 145-62.
34. Alavi A, Sibbald RG, Phillips TJ, et al. What’s new: management of leg ulcers. J Am Acad Dermatol 2016; 74:643-64.
35. Cardinal M, Eisenbud DE, Armstrong DG, et al. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen 2009; 17: 306-11.
36. Williams D, Enoch S, Miller D, Harris K, Price P, Harding KG. Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study. Wound Repair Regen 2005; 13: 131-7.
37. Gethin G, Cowman S, Kolbach DN. Debridement for venous leg ulcers. Cochrane Database Syst Rev 2015; 9: CD008599.
38. König M, Vanscheidt W, Augustin M, Kapp H. Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial. J Wound Care 2005; 14: 320-3.
39. O’Meara S, Al-Kurdi D, Ologun Y, Ovington LG, Martyn-St James M, Richardson R. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2014; 1: CD003557.
40. O’Meara S, Martyn-St James M. Foam dressings for venous leg ulcers. Cochrane Database Syst Rev 2013; 5: CD009907.
41. Comfort EH. Reducing pressure ulcer incidence through Braden Scale risk assessment and support surface use. Adv Skin Wound Care 2008; 21: 330-4.
42. Norton L, Coutts P, Sibbald RG. Beds: practical pressure management for surfaces/mattresses. Adv Skin Wound Care 2011; 24: 324-32.
43. Sprigle S, Sonenblum S. Assessing evidence supporting redistribution of pressure for pressure ulcer prevention: a review. J Rehabil Res Dev 2011; 48: 203-13.
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.